BRAF inhibitor

Kinnate bags $98M to push next-gen targeted cancer drugs

Kinnate is working on treatments for patients who do not have yet have targeted drugs and patients whose cancers develop resistance to available meds.

Amirah Al Idrus Aug 26, 2020 10:00am

How melanoma resists BRAF inhibitors

Nov 7, 2018 8:58am

Unraveling the mysteries of drug resistance in melanoma

Aug 24, 2018 10:34am